热门资讯> 正文
Hims Hers Health 2026年第一季度盈利预览
2026-05-09 05:35
- Hims & Hers Health (HIMS) is scheduled to announce Q1 earnings results on Monday, May 11th, after market close.
- The consensus EPS Estimate is $0.13 and the consensus Revenue Estimate is $616.85M (+5.3% Y/Y).
- Over the last 1 year, HIMS has beaten EPS estimates 0% of the time and has beaten revenue estimates 100% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 3 downward. Revenue estimates have seen 0 upward revisions and 9 downward.
- Recent earnings Analysis from our contributors:Hims Earnings: Stability Could Trigger A Squeeze
More on Hims & Hers Health
- Hims Earnings: Stability Could Trigger A Squeeze
- Hims & Hers, Novo Nordisk: FDA GLP-1 Compounding Ruling May Actually Favor Hims
- FDA Peptide Review, A Big Moment For Hims & Hers (Rating Upgrade)
- Most and least shorted mid-to mega-cap healthcare stocks in May
- Hims rises as J.P. Morgan initiates at Overweight on rich catalyst path
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。